...
search icon
mgrx-img

Mangoceuticals, Inc. Common Stock, Common Stock

MGRX

NAQ

$1.826

+$0.15

(8.93%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.20M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
155.22K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.42
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.49 L
$8.78 H
$1.826

About Mangoceuticals, Inc. Common Stock, Common Stock

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameMGRXSectorS&P500
1-Week Return-7.18%0.35%2.88%
1-Month Return-21.5%-4%0.35%
3-Month Return-46.05%-6.04%-5.27%
6-Month Return-29.11%-5.61%-0.59%
1-Year Return-56.92%-1.39%12.17%
3-Year Return-97.2%6.99%36.64%

Financials

Dec '21Dec '22Dec '23Dec '24
Total Revenue-8.94K731.49K473.26K[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":1.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":64.7,"profit":true}]
Cost of Revenue-4.09K299.99K235.91K[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":1.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":78.64,"profit":true}]
Gross Profit-4.85K431.50K237.35K[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":1.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":55.01,"profit":true}]
Gross Margin-54.26%58.99%50.15%[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":91.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":85.02,"profit":true}]
Operating Expenses17.52K2.00M9.65M8.35M[{"date":"2021-12-31","value":0.18,"profit":true},{"date":"2022-12-31","value":20.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.55,"profit":true}]
Operating Income(17.52K)(1.99M)(9.22M)(7.97M)[{"date":"2021-12-31","value":-1752000,"profit":false},{"date":"2022-12-31","value":-199158200,"profit":false},{"date":"2023-12-31","value":-921889000,"profit":false},{"date":"2024-12-31","value":-797199300,"profit":false}]
Total Non-Operating Income/Expense-(12.95K)11.15K(748.93K)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-116.15,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-6719.3,"profit":false}]
Pre-Tax Income(17.70K)(2.00M)(9.21M)(8.71M)[{"date":"2021-12-31","value":-1770100,"profit":false},{"date":"2022-12-31","value":-199805500,"profit":false},{"date":"2023-12-31","value":-921241700,"profit":false},{"date":"2024-12-31","value":-870722600,"profit":false}]
Income Taxes(70.08K)(224.62K)1.00-[{"date":"2021-12-31","value":-7008000,"profit":false},{"date":"2022-12-31","value":-22462200,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-(1.77M)(9.21M)-[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-177343300,"profit":false},{"date":"2023-12-31","value":-921241800,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations-(2.00M)(7.32M)(8.71M)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-199805500,"profit":false},{"date":"2023-12-31","value":-731802500,"profit":false},{"date":"2024-12-31","value":-870722600,"profit":false}]
Income From Discontinued Operations----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(17.70K)(2.00M)(9.21M)(8.71M)[{"date":"2021-12-31","value":-1770100,"profit":false},{"date":"2022-12-31","value":-199805500,"profit":false},{"date":"2023-12-31","value":-921241700,"profit":false},{"date":"2024-12-31","value":-870614500,"profit":false}]
EPS (Diluted)-(0.08)(5.77)(4.52)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-8,"profit":false},{"date":"2023-12-31","value":-577.32,"profit":false},{"date":"2024-12-31","value":-452.26,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MGRX
Cash Ratio 0.04
Current Ratio 0.05
Quick Ratio 0.05

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MGRX
ROA (LTM) -62.72%
ROE (LTM) -118.31%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MGRX
Debt Ratio Lower is generally better. Negative is bad. 0.09
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.91

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MGRX
Trailing PE NM
Forward PE NM
P/S (TTM) 13.51
P/B 0.60
Price/FCF NM
EV/R 13.77
EV/Ebitda NM

FAQs

What is Mangoceuticals, Inc. Common Stock share price today?

Mangoceuticals, Inc. Common Stock (MGRX) share price today is $1.826

Can Indians buy Mangoceuticals, Inc. Common Stock shares?

Yes, Indians can buy shares of Mangoceuticals, Inc. Common Stock (MGRX) on Vested. To buy Mangoceuticals, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MGRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Mangoceuticals, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Mangoceuticals, Inc. Common Stock (MGRX) via the Vested app. You can start investing in Mangoceuticals, Inc. Common Stock (MGRX) with a minimum investment of $1.

How to invest in Mangoceuticals, Inc. Common Stock shares from India?

You can invest in shares of Mangoceuticals, Inc. Common Stock (MGRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in MGRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Mangoceuticals, Inc. Common Stock shares
What is Mangoceuticals, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Mangoceuticals, Inc. Common Stock (MGRX) is $8.78. The 52-week low price of Mangoceuticals, Inc. Common Stock (MGRX) is $1.49.

What is Mangoceuticals, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Mangoceuticals, Inc. Common Stock (MGRX) is 0.60

What is the Market Cap of Mangoceuticals, Inc. Common Stock?

The market capitalization of Mangoceuticals, Inc. Common Stock (MGRX) is $9.20M

What is Mangoceuticals, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Mangoceuticals, Inc. Common Stock is MGRX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top